Stories > Takeda's HYQVIA Approved as CIDP Maintenance Therapy

Takeda's HYQVIA Approved as CIDP Maintenance Therapy

Advancements in Immunotherapy for Neurol...

Takeda's HYQVIA® Positively Receives CHM...